Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-01-27 | Dr. Lu has an M.D. and MBA and experience in biotech equity research and executive roles; no programming or software engineering experience is described. |
| 2017-06-21 | Lucy Lu, M.D. |
| 2018-01-26 | Dr. Lu’s extensive experience in leadership positions in the pharmaceutical and medical products industries. |
| 2022-01-28 | Dr. Lu obtained her M.D. from the New York University School of Medicine and her M.B.A. from the Leonard N. Stern School of Business at New York University. |
| 2023-01-27 | Dr. Lu obtained her M.D. from the New York University School of Medicine and her M.B.A. from the Leonard N. Stern School of Business at New York University. |
| 2023-06-12 | Lucy Lu, M.D. (10) Consists of (a) 9,800 shares of Common Stock owned directly by Dr. Lu and (b) 70,001 shares of Common Stock subject to stock options. |
| 2024-01-26 | Dr. Lu obtained her M.D. from the New York University School of Medicine and her M.B.A. from the Leonard N. Stern School of Business at New York University. |
| 2025-01-28 | Dr. Lu obtained her M.D. from the New York University School of Medicine and her M.B.A. from the Leonard N. Stern School of Business at New York University. |
Data sourced from SEC filings. Last updated: 2025-08-30